Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.00 | €13.74 | 1271.477% |
| Corcept Therapeutics Inc. | 9 | 0 | 3 | 0 | €24.51 | €35.38 | 44.341% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €214.70 | €247.61 | 15.327% |
| LivaNova plc | 9 | 0 | 3 | 0 | €51.50 | €66.59 | 29.306% |
| Medtronic plc | 10 | 1 | 0 | 0 | €75.24 | €94.38 | 25.439% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €62.00 | €66.53 | 7.305% |
| WAVE Life Sciences Ltd | 8 | 0 | 0 | 0 | €5.45 | €9.10 | 66.987% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.38 | €5.76 | 70.308% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €37.20 | €51.20 | 37.627% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.22 | €4.57 | 106.399% |
| Becton, Dickinson & Co. | 8 | 0 | 0 | 0 | €216.00 | €262.02 | 21.307% |
| Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €4.29 | €10.96 | 155.262% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
| Immunogen Inc. | 7 | 0 | 1 | 0 | €28.97 | - | - |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| BeiGene Ltd ADR | 8 | 1 | 1 | 0 | €150.00 | €255.89 | 70.593% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €85.50 | €97.90 | 14.505% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.72 | €4.63 | 545.649% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.00 | €65.00 | -1.515% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €102.00 | €110.00 | 7.843% |